FDA Inspection
CCRM HoustonCCRM Houston – FDA Inspection, Nov 8, 2022
Record Details
This FDA Inspection record concerns CCRM Houston, with an inspection on November 8, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- CCRM Houston
- Inspection Date
- November 8, 2022
- Product Type
- Biologics
View Company Profile
ID · caaf4ee2-591d-44b0-a74c-dc9f4835a3fb
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1191375
- FDA center
- Biologics
- Project area
- Vaccines and Allergenic Products
Other FDA inspections of CCRM Houston
4| Date | Classification | Office | Project area |
|---|---|---|---|
| September 16, 2025 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| April 3, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 6, 2014 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| May 10, 2012 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for CCRM Houston
- FDA Inspection 1284584 - 2025-09-16
- FDA Inspection 1049725 - 2018-04-03
- FDA Inspection 877840 - 2014-05-06
- FDA Inspection 781326 - 2012-05-10
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.